SCHEMBL16795609

SCHEMBL16795609

C=C(CO)c1ccc(CC)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
PLK1 P53350 1/20 0.45
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
PLAU P00749 1/20 0.38
CYP2A6 P11509 1/20 0.37
TRPA1 O75762 1/20 0.37
IDO1 P14902 1/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13818585 0.94 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL9348304 0.84 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL14072686 0.81 PRSS1 (0.48)
SCHEMBL20716158 0.80 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL20218840 0.78 PLK1 (0.47) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL19453248 0.78 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL6546242 0.78 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL14072690 0.77 CES2 (0.45) ALDH1A1TRPA1
SCHEMBL10413952 0.77 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2PLK1LPLLIPG
SCHEMBL13818521 0.77 BCL2 (0.62) RXRARXRBIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed